Dr. José Antonio Queipo, functional urologist at Sagunto Hospital, shares his view on the potential of NESA technology in addressing pathologies linked to autonomic nervous system dysfunction, especially in patients with pelvic pain and overactive bladder.
In his testimony, he highlights that this is an accessible solution with a favorable cost-benefit ratio and the ability to deliver good results, provided there is proper patient selection. He emphasizes the importance of identifying specific clinical profiles, especially those in which autonomic dysfunction is suspected, to maximize the therapeutic value of this intervention.
Dr. Queipo explains that he discovered NESA technology at the annual SINUG congress, where its innovative approach to autonomic nervous system regulation caught his attention. Since then, he considers it could represent an interesting alternative for patients who currently have effective therapeutic options but with certain limitations, such as posterior tibial nerve stimulation or botulinum toxin.
He also values the progress represented by the fact that reference hospitals have already incorporated this NESA technology, facilitating its future adoption in other centers. In fact, he notes that his hospital already has a real expectation of implementation and patients on a waiting list, given the possibility of expanding and improving the alternatives available in clinical practice.
